StockData
Inhibrx Biosciences, Inc. logo

Inhibrx Biosciences, Inc. (INBX) stock

INBXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 1/30
$69.06−5.12 (-6.90%)

Close on Nov 18, 2026Market cap $1.02BP/E –Yield –

Inhibrx Biosciences market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Inhibrx Biosciences's market cap was $1.33B on Nov 11, 2026, against $1.22B a year earlier. Over the last 5 years it ranged from $110.74M to $1.88B, with a median of $245.56M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$1.33B+16.3%
2025Dec 31, 2025$1.15B+413.8%
2024Dec 31, 2024$222.93M-50.4%
2023Dec 29, 2023$449.26M+86.6%
2022Dec 30, 2022$240.78M-41.9%
2021Dec 31, 2021$414.13M+33.2%
2020Dec 31, 2020$310.83M–

More Inhibrx Biosciences figures

See a number that looks wrong?